Literature DB >> 13651781

Antimalarials in treatment of Sjogren's syndrome.

J M HEATON.   

Abstract

Entities:  

Keywords:  BLOOD GROUPS; CHLOROQUINE/therapeutic use; SJOEGREN SYNDROME/therapy

Mesh：

Substances：

Year:  1959        PMID： 13651781      PMCID： PMC1993725          DOI： 10.1136/bmj.1.5136.1512

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  5 in total

1.  Sjögren's syndrome and systemic lupus erythematosus.

Authors:  J M HEATON
Journal:  Br Med J       Date:  1959-02-21

2.  Plaquenil in the treatment of cutaneous lupus erythematosus.

Authors:  P GOODE
Journal:  Br J Dermatol       Date:  1958-05       Impact factor: 9.302

3.  The ocular complications of chloroquine therapy.

Authors:  H E HOBBS; C D CALNAN
Journal:  Lancet       Date:  1958-06-07       Impact factor: 79.321

4.  Treatment of chronic lupus erythematosus with chloroquine.

Authors:  J R PRAKKEN; S M MOLHUYSEN-VAN DER WALLE
Journal:  Dermatologica       Date:  1954-03

5.  Treatment of lupus erythematosus with mepacrine.

Authors:  F PAGE
Journal:  Lancet       Date:  1951-10-27       Impact factor: 79.321
  5 in total
  1 in total

1.  [Changes in the human electro-retinogram during long-term resochin therapy].

Authors:  B SCHMIDT; W MUELLER-LIMMROTH; G HEINMUELLER; W BOEKE; A BAEUMER
Journal:  Klin Wochenschr       Date:  1961-02-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.